Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-26-032048

Director sold 8,400 shares at an average $78.50 ($659,387)

  • Director acquired 8,400 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

STARR CHRISTOPHER M · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-01 Exercise or conversion : show line 1 in the form 10b5-1 +8,400 $0.01 $42 13,573 D
2026-10-01 Sale : show line 2 in the form 10b5-1 −4,631 $78.09 $361,635 8,942 D
2026-10-01 Sale : show line 3 in the form 10b5-1 −2,970 $78.82 $234,095 5,972 D
2026-10-01 Sale : show line 4 in the form 10b5-1 −799 $79.67 $63,656 5,173 D
Open-market sales · 8,400 sh · avg $78.50 · $659,387

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-01 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option −8,400 8,400 D
Loading xslF345X06/rdgdoc.xml…